Source:http://linkedlifedata.com/resource/pubmed/id/20354166
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-4-6
|
pubmed:abstractText |
This perspective on Deng et al. (beginning on p. 424 in this issue of the journal) examines the link between NF-kappaB and lung tumorigenesis. Experiments in genetically engineered mouse models of lung cancers are elucidating protumorigenic roles of NF-kappaB activation in lung cancer pathogenesis. Our growing understanding of the tumor-promoting NF-kappaB downstream effector pathways could lead to the development of novel approaches for lung cancer therapy and chemoprevention.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1940-6215
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2010 AACR.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
403-5
|
pubmed:dateRevised |
2011-5-25
|
pubmed:meshHeading | |
pubmed:year |
2010
|
pubmed:articleTitle |
NF-kappaB fans the flames of lung carcinogenesis.
|
pubmed:affiliation |
Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. Kwong1@partners.org
|
pubmed:publicationType |
Journal Article,
Comment,
Review
|